Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Research in the College of Veterinary Medicine at Kansas State University is leading to a better understanding of the molecular interactions in the thyroid gland related to cystic fibrosis.
A genetic disorder, cystic fibrosis affects the function of epithelia, the tissues formed of cells that secrete and absorb an array of substances important for health.
The university's Peying Fong, associate professor of anatomy and physiology, has received a $285,000 grant from the Department of Health and Human Services in support of her study, "CFTR Regulation of Thyroid Transport."
"We are looking at a cellular mechanism that is essential to production of thyroxine and triiodothyronine, which are hormones that modulate development, growth and metabolism in both prenatal and postnatal cell life," Fong said. "Iodide is an essential component of these thyroid hormones. Its rarity in the environment challenges the thyroid to orchestrate a remarkable series of transport processes that are critical for hormone synthesis."
In addition to actively extracting iodidethrough the circulation process, thyroid cells must also translocate iodide into a central compartment within thyroid follicles, where it begins to combine with thyroglobulin to form the precursor to thyroid hormone.
"Through this study, we are seeking to better understand the molecular interactions between the Cystic Fibrosis Transmembrane Conductance Regulator, or CFTR, and SLC5A8, which are two transport proteins found in thyroid," Fong said. "These proteins may play a role in moving iodide into the follicular lumen."
Fong's project is classified by the National Institutes of Health as an R15 Academic Research Enhancement Award. The NIH uses such awards to strengthen research environments at educational institutions as well as to promote the exposure of students to academic research. This is a renewable grant and helps cover expenses for a period of up to three years.
Fong said that the groundwork for her research project originally began with funding from the Kansas State University's Center of Biomedical Research Excellence, or COBRE, and NIH project "Epithelial Function in Health and Disease"; a grant-in-aid from the American Heart Association Midwest Affiliate; and an Innovative Research Award from the university's Johnson Center for Basic Cancer Research.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Cystic Fibrosis category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Kansas State University. "The thyroid gland and cystic fibrosis." Medical News Today. MediLexicon, Intl., 31 Oct. 2013. Web.
8 Dec. 2013. <http://www.medicalnewstoday.com/releases/268107>
Kansas State University. (2013, October 31). "The thyroid gland and cystic fibrosis." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/268107.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.